PAR · EL.PA
EssilorLuxottica S.A.
€178.20+€0.50 (+0.28%)
EssilorLuxottica S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.97% below the high.
Loading market information…
SHZ · 300015.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Aier Eye Hospital Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Aier Eye Hospital Group Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 2.36% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Aier Eye Hospital Group Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of CN¥0.11. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aier Eye Hospital Group Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic healthcare services and institutions. Its comprehensive medical offerings encompass specialties such as the diagnosis and treatment of fundus diseases, optometry, refractive correction, glaucoma, corneal conditions, and cataracts. Beyond direct patient care, the company also conducts training courses focused on cataract prevention and management. The group boasts an extensive international footprint, operating approximately 500 ophthalmic facilities across mainland China, with additional presences including 86 in Europe, 1 in the United States, 7 in Hong Kong, and 12 throughout Southeast Asia. Founded in 2007, Aier Eye Hospital Group maintains its headquarters in Changsha, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥5.48B-2.37% vs estimate |
| Q1 2025 | Apr 24, 2025 | CN¥0.01-75.0% vs estimate | CN¥6.03B-3.33% vs estimate |
|---|
| Q3 2024 | Dec 31, 2024 | CN¥0.01 | CN¥4.68B |
|---|
| Q3 2024 | Oct 31, 2024 | CN¥0.150.0% vs estimate | CN¥5.76B-8.94% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€178.20+€0.50 (+0.28%)
EssilorLuxottica S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.97% below the high.
¥25,875-¥455 (-1.73%)
HOYA Corporation’s quoted price sits in the lower half of its reported 52-week range, 14.88% below the high.
CHF 58.76+CHF 1.12 (+1.94%)
Alcon Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.02% below the high.
₹681.75-₹7.95 (-1.15%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 5.97% below the high.
$60.34+$0.93 (+1.57%)
The Cooper Companies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.83% below the high.
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
CN¥35.42+CN¥1.21 (+3.54%)
Topchoice Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.17% below the high.
CN¥4.45+CN¥0.07 (+1.6%)
Xi'an International Medical Investment Company Limited’s quoted price sits in the lower half of its reported 52-week range, 28.11% below the high.
